Recommendations developed for management of hidradenitis suppurativa

AI Insight

The American Academy of Dermatology and the Hidradenitis Suppurativa Foundation have jointly published evidence-based clinical guidelines for managing hidradenitis suppurativa (HS), a chronic skin condition. These recommendations were published in the Journal of the American Academy of Dermatology to provide standardized, research-supported approaches for treating this condition. The guidelines aim to help healthcare providers make informed decisions about HS management based on current scientific evidence.

Why it matters

Hidradenitis suppurativa is a chronic inflammatory skin disease that significantly impacts patients' quality of life, and standardized treatment guidelines can improve patient outcomes by ensuring consistent, evidence-based care across different healthcare settings. These recommendations provide clinicians with clear guidance on therapeutic options and management strategies.